Scientists assumed that one specific immune cell subtype was required for mRNA vaccination to activate the immune system. But ...

Updated clinical practice guidelines on the use of vaccines to prevent seasonal COVID-19, influenza, and respiratory ...

New findings reveal mRNA vaccines engage different dendritic cell subtypes to activate anti-tumor immunity, providing ...

Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana”), a biotechnology company developing its lead candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody, announces the ...

Researchers analyzing 761 first-trimester pregnancies found that SARS-CoV-2 was rarely detected in placental tissues, ...

The average human has about 1.8 trillion immune cells. These cells patrol the body for bacteria, viruses, cancers, and other ...

Keytruda, manufactured by the US-based Merck & Co, is an immunotherapy drug that has become one of the world’s best-selling ...

We're keeping an eye on new influenza and SARS-CoV-2 viral variants. Here's what we know about those viruses—and your immune ...

Bishop has received support for the present manuscript from the National Institute for Health Research (NIHR)-Leicester Biomedical Research Centre. Hamrouni has received support for the present ...

As people grow older, they become more vulnerable to illnesses such as the flu and COVID-19. Many families notice that what ...